BOAN BIOTECH
Boan Biotech is a biopharmaceutical company developing therapeutic antibodies with a focus on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology.
BOAN BIOTECH
Industry:
Biotechnology Health Care Pharmaceutical Product Research Therapeutics
Founded:
2013-01-01
Address:
Yantai, Liaoning, China
Country:
China
Website Url:
http://www.boan-bio.com
Status:
Active
Contact:
86 0535-4379111
Total Funding:
210.9 M CNY
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail GlobalSign Alibaba HiChina DNS
Current Advisors List
Current Employees Featured
Investors List
Advantech Capital
Advantech Capital investment in Series B - Boan Biotech
Yantai Wensen
Yantai Wensen investment in Series B - Boan Biotech
Shandong Finance Investment Group
Shandong Finance Investment Group investment in Series B - Boan Biotech
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series B - Boan Biotech
Yunnan Felix
Yunnan Felix investment in Series B - Boan Biotech
More informations about "Boan Biotech"
Boan Bio
Boan Biotech，Shandong Boan Biotech， Boan Innovative Antibodies，Boan Biosimilar Established in 2013, Boan Biotech is a fully-integrated biopharmaceutical company, specializing in the research & development, …See details»
Boan Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 86 0535-4379111 Boan Biotech is a biopharmaceutical company developing therapeutic antibodies with a focus on key therapeutic …See details»
Shandong Boan Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Explore Shandong Boan Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 34 clinical trials, 1 news, and 19 literature, Disease Domain:Neoplasms, …See details»
Boan Biotech Company Profile 2024: Stock …
Boan Biotech General Information Description. Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics …See details»
博安生物，山东博安，博安新型抗体，博安 ... - Boan Bio
博安生物，山东博安，博安新型抗体，博安生物类似药，贝伐珠单抗，地舒单抗 博安生物成立于2013年，是一家全面综合性生物制药公司，是一家全面综合性生物制药公司，专业从事生物药开发、生产和商业化专注于肿瘤、自身免疫、眼科和 …See details»
Shandong Boan Biotechnology Co., Ltd. (山东博安生物技术股份有 …
了解Shandong Boan Biotechnology Co., Ltd. (山东博安生物技术股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的34项临床试验, 399篇新闻和19篇文献，疾病领域:肿瘤，内 …See details»
Boan Boston LLC - MassBio
Boan Biotech is a fully integrated biopharmaceutical company, specializing in the research & development, manufacturing, and commercialization of novel therapeutic antibodies, cell and …See details»
Luye Pharma Acquires Boan with Strategic Plans in …
Boan has submitted 3 patent applications in China for protection of the preparation process in respect of its biosimilar products LY01008 and LY09004, over 20 patent applications in China in respect of its innovative products and …See details»
Jiang Hua – CEO, Boan Biotech - pharmaboardroom.com
May 28, 2024 Boan Biotech CEO Jiang Hua outlines the Luye Pharma-acquired company's approach, securing stable revenues through its biosimilars while pursuing novel platforms and innovative drug development. She provides …See details»
Boan Biotech - Products, Competitors, Financials, Employees ...
Dec 30, 2022 Boan Biotech (6955.HK) is a biopharmaceutical company that develops antibodies and drugs for cancer, the central nervous system, diabetes, and immune diseases. Use the …See details»
博安生物 | 项目信息-36氪
博安生物是绿叶制药集团的附属公司，于2013年成立，是一家全面综合性生物制药公司，专业从事治疗用抗体开发，专注于肿瘤科、自身免疫、疼痛和内分泌疾病。该公司的抗体发现活动围绕 …See details»
Contact us - Boan Biotech，Shandong Boan Biotech， Boan …
Boan Biotech，Shandong Boan Biotech， Boan Innovative Antibodies，Boan Biosimilar Established in 2013, Boan Biotech is a fully-integrated biopharmaceutical company, …See details»
Boan Bio Closes ￥682M Strategic Financing, Expanding Biological …
Jan 12, 2021 Boan Bio is also actively exploring cutting-edge technologies. Its cell therapy products use non-viral vectors to prepare CAR T-cells for advanced solid tumors. It continues …See details»
Boan Biotech Reaches Strategic Collaboration Agreement with
Boan Biotech, a subsidiary of Luye Pharma Group, announced today that it has signed a Memorandum of Understanding with Merck, a world-leading science and technology company, …See details»
博安生物-B，分拆自绿叶制药，成功在香港IPO上市 - 雪球
Dec 30, 2022 $博安生物-B(06955)$ $绿叶制药(02186)$ 2022年12月30日，山东博安生物技术股份有限公司 Shandong Boan Biotechnology Co., Ltd.(以下简称“博安生物”)(06955.HK)，成功 …See details»
BLA for Boan's Boyounuo® (Bevacizumab) Accepted in Brazil
Apr 11, 2023 In terms of the needs of local patients, data from the World Health Organization's International Agency for Research on Cancer shows that, in 2020, lung cancer and colorectal …See details»
Boan Biotech's Biologics License Application for Boyounuo® …
Apr 12, 2023 Envisioned to be "a leading global biopharmaceutical company", Boan Biotech develops biologics for both Chinese and international markets, including Europe and the U.S. …See details»
Boan Biotech obtains regulatory approval for their LY-CovMab …
Mar 24, 2021 Horizon Discovery is pleased to share that Shandong Boan Biotechnology Co. Ltd. (Boan Biotech) a fully integrated biopharmaceutical company specializing in therapeutic …See details»
Boan Biotech Authorizes Zencore Biologics to Use Its BA-HIEXcell ...
Jan 30, 2024 The platform can enhance the efficiency of biologics development by creating stable and highly expressed cell lines . Yantai, China, January 30, 2024-- Boan Biotech …See details»